Careful here folks. This goes against the mantra that big pharma is hiding all those cheap and effective treatments and doctors are in on it and murdering people with ventilators for waterfront mansions.
“Our trial has found that fluvoxamine, an inexpensive existing drug, reduces the need for advanced disease care in this high-risk population. A 10-day course of fluvoxamine costs approximately US$4 even in well-resourced settings.21 Our study compares favourably with the treatment effects of more expensive treatments including monoclonal antibodies for outpatient treatment.20, 22, 23 The absolute number of serious adverse events associated with fluvoxamine was lower than for placebo and this might reflect the modulatory effect of fluvoxamine on systemic inflammation in these participants. Lower respiratory tract infections were reported less frequently in patients in the fluvoxamine group than those in the placebo group. This is concordant with the reduction of hospital admissions in patients with confirmed COVID-19 treated with fluvoxamine, and the numerically lower number of patients requiring mechanical ventilation.”
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext